FDA Adverse Event Injury Summary report: N

255

MDR report key: 17015289 · Received May 26, 2023

Report

Report Number
3006723646-2023-00038
Event Type
Injury
Date Received
May 26, 2023
Date of Event
February 1, 2023
Report Date
May 6, 2023
Manufacturer
HOYA SURGICAL OPTICS, INC.
Product Code
HQL
PMA / PMN Number
P080004
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THIS INITIAL REPORT IS BEING SUBMITTED TO FDA FOR A REPORTABLE EVENT THAT OCCURRED OUTSIDE THE USA. NOTE: DELAYED EMDR SUBMISSION WAS DUE TO FDA ESG WEBTRADER ACCOUNT SYSTEM SOFTWARE ISSUES, PER FDA ESG HELP DESK TICKET # (B)(4). HOYA DUE DILIGENCE IS DOCUMENTED UNDER INTERNAL ISSUE-(B)(4). HAPTIC DAMAGE IS INDICATED AS A POTENTIAL MALFUNCTION RELATED TO THE IOL, AS COVERED UNDER THE WARNINGS SECTION OF THE PRODUCT'S INSTRUCTIONS FOR USE (IFU). THE PRODUCT WAS RETURNED TO THE MANUFACTURER. THE INVESTIGATION WAS CONDUCTED, WITH THE METHODS AND RESULTS AS NOTED BELOW. APPEARANCE CHECK RESULT WAS CONSISTENT TO REPORTED INFORMATION. NO ABNORMALITIES WERE FOUND IN THE PRODUCTION AND INSPECTION RECORDS OF THE PRODUCT. (SERIAL NO.: (B)(6); MODEL: 255) THE DYE TEST RESULT SHOWED THE INJECTOR TIP WAS PROPERLY COATED. PROPER COATING ALLOWS THE LENS TO ADVANCE. WE COULD RELEASE A RE-INSTALLED IOL FROM THE RETURNED INJECTOR WITHOUT ANY PROBLEMS. THE EXACT ROOT CAUSE OF THE EVENT WAS NOT DETERMINED. HOWEVER, BASED ON AVAILABLE INFORMATION, WE BELIEVE THIS EVENT WAS NOT CAUSED BY OUR PRODUCT QUALITY. CAPA-22-0009 HAS BEEN INITIATED FOR "DAMAGED HAPTIC" COMPLAINTS.

Description of Event or Problem · 0

DAMAGED HAPTIC AFTER IMPLANTATION. THE DOCTOR CUT AND EXPLANTED THE IOL FROM THE EYE SINCE HE NOTICED THE TRAILING HAPTIC WAS SEPARATED AT THE TIP. THE HAPTIC PIECE REMAINED IN THE INJECTOR. PATIENT IMPACT: INTRA-OPERATIVE EXPLANTATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1887280 255 INTRAOCULAR LENS HQL HOYA SURGICAL OPTICS, INC. 255 (+ 19.00 D)

Patients

Seq Age Sex Outcome Treatment
1 Unknown Required Intervention